SB 2499Session 114
TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
Progress
- Introduced
- In committee
- Passed one chamber Not yet
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
What this bill would cost
Fiscal notes are prepared by the state’s budget staff and reflect the bill as written at the time.
Legislative history
-
Senate
Assigned to General Subcommittee of Senate Commerce and Labor Committee
-
Senate
Passed on Second Consideration, refer to Senate Commerce and Labor Committee
-
Senate
Placed on Senate Commerce and Labor Committee calendar for 3/10/2026
-
Senate
Approved by Delayed Bills Committee
-
Senate
Introduced, Passed on First Consideration
-
Senate
Filed for introduction
-
Senate
Refer to Senate Delayed Bills Committee